![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
v_s_chttps://www.dw.com/en/israels-clever-coronavirus-vaccination-strategy/a-56586888
"...
According to the agreement, Israel pays significantly more than the EU for each vaccine dose of the BioNTech-Pfizer vaccine, reportedly about €23 ($28) per dose compared with the €12 paid by the EU.
In addition, the Israeli state retains product liability. The European Union, on the other hand, was very keen that BioNTech-Pfizer continue to be liable for the safety of the product.
Most importantly, Israel's government agreed with vaccine manufacturers to provide weekly data from the vaccination campaign to them. This includes infection and vaccination numbers, as well as patient demographics such as age and gender. The data is sent to Pfizer anonymously, according to Israeli officials.
Thanks to the digitized health care system in Israel, the pharmaceutical companies not only receive data quickly and reliably, but above all they get much more data than they would from any other study. It is an invaluable source of information for the pharmaceutical companies.
In return, the manufacturers committed to supplying Israel with vaccines until immunization of 95% of the population is achieved.
..."
Европейцы сэкономили 5 миллиардов. А потеряют, я подозреваю, намного больше. :-(
"...
According to the agreement, Israel pays significantly more than the EU for each vaccine dose of the BioNTech-Pfizer vaccine, reportedly about €23 ($28) per dose compared with the €12 paid by the EU.
In addition, the Israeli state retains product liability. The European Union, on the other hand, was very keen that BioNTech-Pfizer continue to be liable for the safety of the product.
Most importantly, Israel's government agreed with vaccine manufacturers to provide weekly data from the vaccination campaign to them. This includes infection and vaccination numbers, as well as patient demographics such as age and gender. The data is sent to Pfizer anonymously, according to Israeli officials.
Thanks to the digitized health care system in Israel, the pharmaceutical companies not only receive data quickly and reliably, but above all they get much more data than they would from any other study. It is an invaluable source of information for the pharmaceutical companies.
In return, the manufacturers committed to supplying Israel with vaccines until immunization of 95% of the population is achieved.
..."
Европейцы сэкономили 5 миллиардов. А потеряют, я подозреваю, намного больше. :-(
